Trial
NCT00298272
Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
Hoffmann-La Roche; Genentech, Inc.
Condition
Rheumatoid Arthritis
Intervention
IDEC-C2B8 (rituximab)
Why stopped
Sponsor decided to end long term extension phase for business reasons unrelated to safety.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-28